Randomised controlled trials for evaluating the prescribing impact of information meetings led by pharmacists and of new information formats, in General Practice in Italy

BMC Health Services Research

Volumn 7, Issue , 2007, Pages

  Magrini, Nicola ^a   Formoso, Giulio ^a   Marata, Anna Maria ^a   Capelli, Oreste ^a   Maestri, Emilio ^a   Voci, Claudio ^a   Nonino, Francesco ^a   Brunetti, Massimo ^a   Paltrinieri, Barbara ^a   Maltoni, Susanna ^a   Magnano, Lucia ^a   Bonacini, Maria Isabella ^a   Daya, Lisa ^a   Viani, Nilla ^a  

^a AUSL Modena   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIANDROGEN; ANTIDEPRESSANT AGENT; AZITHROMYCIN; BICALUTAMIDE; BISPHOSPHONIC ACID DERIVATIVE; BRONCHODILATING AGENT; BUPRENORPHINE; CLARITHROMYCIN; CORTICOSTEROID; DOXAZOSIN; DUTASTERIDE; ESCITALOPRAM; ESOMEPRAZOLE; FENTANYL; FINASTERIDE; FOSFOMYCIN; LEVOCETIRIZINE; MACROLIDE; MORPHINE; NORFLOXACIN; OPIATE; PROTON PUMP INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RISEDRONIC ACID; SALMETEROL;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COST; FEASIBILITY STUDY; FEMALE; GENERAL PRACTICE; HEALTH ECONOMICS; HUMAN; INTERVENTION STUDY; MALE; MEDICAL INFORMATION SYSTEM; NORMAL HUMAN; OUTCOME ASSESSMENT; PHARMACIST; PHYSICIAN; PRESCRIPTION; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL; SALARY; SAMPLE SIZE; CLINICAL COMPETENCE; CLINICAL PROTOCOL; DRUG USE; EDUCATION; EVIDENCE BASED MEDICINE; GROUP PROCESS; INFORMATION DISSEMINATION; ITALY; MASS COMMUNICATION; METHODOLOGY; PRIMARY HEALTH CARE; PROFESSIONAL STANDARD; STANDARD;

CLINICAL COMPETENCE; CLINICAL PROTOCOLS; DIFFUSION OF INNOVATION; DRUG UTILIZATION REVIEW; EVIDENCE-BASED MEDICINE; FAMILY PRACTICE; GROUP PROCESSES; HUMANS; INFORMATION DISSEMINATION; ITALY; PHARMACISTS; PRESCRIPTIONS, DRUG; PRIMARY HEALTH CARE; PROFESSIONAL ROLE; RESEARCH DESIGN;

EID: 36649025274     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-7-158     Document Type: Article

References (18)

1. The pharmaceutical industry as an informant. J Collier I Iheanacho, Lancet 2002 360 1405 9 10.1016/S0140-6736(02)11394-8 12424005
2. Accountability of the pharmaceutical industry. MN Dukes, Lancet 2002 360 1682 4 10.1016/S0140-6736(02)11599-6 12457804
3. Failures of the therapeutic chain as a cause of drug ineffectiveness: promotion, misinformation, and economics work better than needs. A Figueras JR Laporte, BMJ 2003 326 895 6 12714454 10.1136/bmj.326.7395.895
4. Evidence b(i)ased medicine - selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. H Melander J Ahlqvist-Rastad G Meijer B Beermann, BMJ 2003 326 1171 3 12775615 10.1136/bmj.326.7400.1171
5. Characteristics of general practitioners who frequently see drug industry representatives: national cross sectional study. C Watkins L Moore I Harvey P Carthy E Robinson R Brawn, BMJ 2003 326 1178 9 12775618 10.1136/bmj.326.7400. 1178
6. Psychological Aspects of Gifts From Drug Companies. D Kats P Mansfield R Goodman L Tiefer J Merzet, JAMA 2003 290 2404 5 10.1001/jama.290.18.2404-c
7. Barriers and bridges to evidence-based clinical practice. B Haynes A Haines, BMJ 1998 317 273 6 9677226
8. Doctors' knowledge about evidence based medicine terminology. JD Woodcock S Greenley S Barton, BMJ 2002 324 929 30 11964325 10.1136/bmj.324.7343.929
9. Research in medical education: three decades of progress. G Norman, BMJ 2002 324 1560 2 12089095 10.1136/bmj.324.7353.1560
10. Are we providing doctors with the training and tools for lifelong learning? AF Shaughnessy DC Slawson, BMJ 1999 319 1280 2 10559034
11. A qualitative study of evidence in primary care: what the practitioners are saying. W Putnam PL Twohig FI Burge LA Jackson JL Cox, CMAJ 2002 166 1525 30 12074118
12. Educational outreach visits: effects on professional practice and health care outcomes. MA Thomson O'Brien AD Oxman DA Davis RB Haynes N Freemantle EL Harvey, The Cochrane Database of Systematic Reviews 1997 4
13. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes. J Beney LA Bero C Bond, The Cochrane Database of Systematic Reviews 2000 2 10908471
14. Audit and feedback: effects on professional practice and health care outcomes. G Jamtvedt JM Young DT Kristoffersen MA Thomson O'Brien AD Oxman, The Cochrane Database of Systematic Reviews 2003 3 12917891
15. Effectiveness and efficiency of guideline dissemination and implementation strategies. JM Grimshaw RE Thomas G MacLennan C Fraser CR Ramsay L Vale P Whitty MP Eccles L Matowe L Shirran M Wensing R Dijkstra C Donaldson, Health Technol Assess 2004 8 6 14960256
16. Rational Prescribing in Primary Care (RaPP): a cluster randomized trial of a tailored intervention. A Fretheim AD Oxman K Havelsrud S Treweek DT Kristoffersen A Biørndal, PLoS Med 3 6 e134 16737346 10.1371/journal. pmed.0030134
17. Social marketing: should it be used to promote evidence-based information? G Formoso AM Marata N Magrini, Soc Sci Med 2007 64 949 53 10.1016/j.socscimed.2006.09.022 17141384
18. Methods for the Economic Evaluation of Health Care Programmes. MF Drummond MJ Sculpher GW Torrance BJ O'Brien GL Stoddart, Oxford University Press Third 2005